Clinical Trial

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-10-01; most recent amendment 2026-05-29.
Status change: Not Yet Recruiting → Recruiting 2025-03-19
Trial Details
NCT Number NCT06625671
Lead Sponsor DualityBio Inc.
Conditions Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus
Enrollment 148 participants
Start Date 2024-10-04
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-02